IFG Advisory’s Celgene Corp CELG Stock Holding History

IFG Advisory’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,959	Closed	-$204K	–	356
2017 Q4	$204K	Buy	+1,959	New	+$221K	0.05%	311

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IFG Advisory's CELG Position: Q1 2018 in Review

IFG Advisory sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 1,959 shares — an estimated $204K sold.

IFG Advisory first reported a position in CELG in Q4 2017 and held it in 1 quarter. The position peaked at $204K in Q4 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

IFG Advisory reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
IFG Advisory sold 1,959 Celgene Corp shares in Q1 2018, an estimated $204K.
IFG Advisory first reported a position in Celgene Corp in Q4 2017 and held it in 1 quarter.
IFG Advisory's Celgene Corp position peaked at $204K in Q4 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on IFG Advisory's 13F filing for Q1 2018, filed 26 Apr 2018.